Mpox: Not the Next COVID-19, But Still a Concern

Overview

Mpox, a virus related to smallpox, has seen an increase in cases worldwide, sparking concerns about its potential impact. However, experts believe it is unlikely to become a global pandemic like COVID-19.

Differences from COVID-19

Unlike COVID-19, mpox:

• Spreads primarily through close physical contact, rather than respiratory droplets
• Has a longer incubation period (up to 21 days)
• Causes distinct skin lesions that can take weeks to heal

Prevention and Treatment

Preventing mpox infection involves:

• Avoiding contact with infected people or animals
• Practicing good hygiene, such as handwashing and disinfecting surfaces
• Getting vaccinated (the smallpox vaccine is effective against mpox)

Treatment for mpox includes antiviral medications and supportive care to manage symptoms.

Current Situation

As of August 2022, mpox cases have been reported in over 100 countries, primarily among men who have sex with men.
While the number of cases is increasing, the World Health Organization (WHO) does not currently consider mpox a global health emergency.

Likelihood of a Pandemic

Experts believe that mpox is unlikely to cause a pandemic for several reasons:

• It is less contagious than COVID-19
• There is an effective vaccine available
• Public health measures, such as contact tracing and isolation, can help control its spread

Conclusion

While mpox is a serious disease, it is not expected to become a global pandemic like COVID-19. However, it is important to remain vigilant, take preventive measures, and seek medical attention if symptoms develop.